Latest posts tagged with #nirsevimab on Bluesky
JAMA article: "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses study design, participants, exposures, outcomes, and measures.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/4bj1lga
#RSV: #Nirsevimab (BEYFORTUS) für #Säuglinge versus #Impfung Schwangerer
In einer Kohortenstudie werden Säuglinge nach passiver Immunisierung etwas seltener wegen RSV-assozierter unterer #Atemwegsinfektion hospitalisiert als bei aktiver Immunisierung der schwangeren Mütter.
Die Januar-Ausgabe ist erschienen – Themen: #Lecanemab (LEQEMBI) bei früher #ALZHEIMER-Erkrankung – Kardiovaskuläre Daten zu #Tirzepatid (MOUNJARO) bei Typ-2-Diabetes – #RSV: #Nirsevimab (BEYFORTUS) für Säuglinge versus Impfung Schwangerer – u.a.
www.arznei-telegramm.com/archiv/2026/1
- #Nirsevimab use in the 2023-24 season led to a significant reduction in RSV #bronchiolitis cases in both hospital & ambulatory settings, even with different RSV strains predominating.
- A study in Galicia, 🇪🇸(NIRSE-GAL) found that the benefits of nirsevimab extended beyond 1st year,
RSV Prevention Pays Off Big. Vaccinations and use of antibody therapy has significantly reduced infections and hospitalizations. #rsv #newborns #vaccine #nirsevimab #hospitalization
#Nirsevimab may help prevent severe respiratory illnesses beyond #RSV in infants, young kids
The monoclonal antibody was tied to a 62% effectiveness against all-cause lower respiratory tract infection hospitalizations.
www.cidrap.umn.edu/r...
Photo: Wirestock / iStock
Inmunización pasiva del niño con nirsevimab se asocia con menor riesgo de hospitalización relacionada con el virus sincicial respiratorio y de resultados graves #RSV #nirsevimab #newborns lnkd.in/e3qVXRdr jamanetwork.com/journals/jam...
#RSV-#Impfstoff #Nirsevimab
während der #Schwangerschaft schützt Babys unter 6 Monaten:
-Arztbesuche wegen RSV werden um ~ 2/3 reduziert
-Krankenhausaufenthalte um ~70 %
Zusätzlich wenn schwanger dann #MaskeAuf -sie saufen ja auch nicht während der Schwangerschaft
jamanetwork.com/journals/jam...
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/4pg9vtw
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
From @jama.com: Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/3Y6uMed
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/45b5jEc
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/44GMGI6
If you missed it:
The FDA is launching a safety review of #RSV preventive monoclonal antibodies #nirsevimab and #clesrovimab. Reuters reported that FDA officials made inquiries into the RSV preventive therapies in the summer. #medsky
Full details: www.contemporarypediatrics.com/view/reports...
¿Cómo cambia la vacuna del VRS en España este invierno?
#VRS #Nirsevimab #Bronquiolitis #Vacunas #Sanidad #Arexvy #Abrysvo #mRESVIA #Embarazo #Mayores #SaludPública #España #3dediciembre #felizmiercoles
donporque.com/vacuna-contr...
you’ll read several success papers about #nirsevimab and #RSV but to make it a successful and long term sustainable interventions you need to read also of out chorus provocative voices, like this one !
rdcu.be/ePXTa
#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs.
Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...
#Nirsevimab prevents #RSV cases in young kids for 1 year but maybe not beyond, data suggest
The findings have implications for scheduling repeat dosing in eligible children, the authors say.
www.cidrap.umn.edu/r...
Maternal vaccine and nirsevimab cut RSV hospitalizations
A maternal RSV vaccine given during pregnancy and the monoclonal antibody nirsevimab have been shown to cut RSV hospitalizations in infants, according to recent data. Read more: getnews.me/maternal-vaccine-and-nir... #rsv #maternalvaccine #nirsevimab
Single-Dose Antibody Nirsevimab Cuts Infant RSV Hospitalizations by 80%
Data show a single dose of nirsevimab (Beyfortus) cut RSV‑related infant hospitalizations by about 80% in a review of 50 studies; CDC recommends a 50 mg dose for babies under 11 lb. getnews.me/single-dose-antibody-nir... #nirsevimab #rsv
Das IQWiG führte eine Überprüfung des Nutzens für Kinder ohne erhöhtes Risiko für #RSV-Erkrankungen durch: Die Vorbeugung mit #Nirsevimab verhindert zwar keine Todesfälle, dennoch zeigen sich in der ersten Saison der Kinder deutlich positive Effekte❄️(€)
gutepillen-schlechtepillen.de/rsv-impfung-...
Timing of maternal vaccination, #nirsevimab to avert #RSV in infants may influence cost-effectiveness
For infants born from October to February, maternal vaccination was cost-effective, but nirsevimab was cost-effective only for those born in fall.
www.cidrap.umn.edu/r...
Στα #πρόωρα #μωρά στο #Ηνωμένο #Βασίλειο θα προσφερθεί μια νέα ένεση μακράς διάρκειας για την προστασία τους από τον Αναπνευστικό Συγκυτιακό #Ιό #RSV αργότερα φέτος.
Η νέα ένεση, #Nirsevimab, θα χορηγηθεί σε μωρά υψηλού κινδύνου, συμπεριλαμβανομένων εκείνων που γεννήθηκαν πολύ πρόωρα. #health #jab
Respiratory syncytial virus poses a major threat to infants, and nirsevimab shows strong potential for broad preventive protection.
#Meded #SoMe4PedSurg #Pediatrics #PublicHealth #RSV #Immunization #Nirsevimab
link.springer.com/article/10.1...
Este hilo forma parte de mi tesis doctoral sobre programas de inmunización en España.
Gracias por leer este hilo.🧵
Si tienes recién nacidos cerca… ya sabes cómo protegerlos. 💉
#HiloTesis #VRS #Nirsevimab @uv.es @ucciuv.bsky.social
Hasta hace poco, solo los bebés con factores de riesgo recibían una protección especial: un anticuerpo llamado palivizumab, que requería cinco dosis.
Pero en 2023, España dio un paso más: introdujo un nuevo anticuerpo para todos los recién nacidos: #nirsevimab. 💉
¿Qué tienen en común un recién nacido, el invierno… y un anticuerpo?
Hoy te cuento cómo un tratamiento nuevo puede cambiar la historia del virus respiratorio sincitial 🦠 #VRS en recién nacidos.
🧵👇
#HiloTesis #Nirsevimab
@crueuniversidades.bsky.social @filarramendi.bsky.social @ucciuv.bsky.social
New study analyses real-world impact of #nirsevimab on reducing infant emergency visits & admissions for lower respiratory tract infections in Spain vs countries without the intervention #RSV #Pediatrics @buonsenso.bsky.social
Read the full Article👇
www.thelancet.com/journals/lan...
This analysis aims to evaluate #nirsevimab efficacy at 180 days after dosing, a period exceeding the typical 5-month RSV season.
www.thelancet.com/journals/lan... @thelancet.com
#RSVProphylaxe mit #Nirsevimab: Vorteile für gesunde Kinder in der ersten RSV-Saison
Mit dem Antikörper Nirsevimab immunisierte Kinder erkranken deutlich seltener an RSV-bedingten Infektionen der unteren Atemwege.
www.iqwig.de/presse/press...
#RSVProphylaxe mit #Nirsevimab: Vorteile für gesunde Kinder in der ersten RSV-Saison
Mit dem Antikörper Nirsevimab immunisierte Kinder erkranken deutlich seltener an RSV-bedingten Infektionen der unteren Atemwege […]
